Extracranial giant cell arteritis: A narrative review

被引:0
|
作者
Lensen, K. D. F. [1 ,2 ]
Voskuyl, A. E. [3 ]
Comans, E. F. I. [4 ]
van der Laken, C. J. [3 ]
Smulders, Y. M. [1 ,2 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
来源
NETHERLANDS JOURNAL OF MEDICINE | 2016年 / 74卷 / 05期
关键词
Giant cell arteritis; vasculitis; arteritis; extracranial; POSITRON-EMISSION-TOMOGRAPHY; LARGE-VESSEL VASCULITIS; TERM-FOLLOW-UP; NONINFECTIOUS ASCENDING AORTITIS; PLACEBO-CONTROLLED TRIAL; POPULATION-BASED COHORT; TEMPORAL ARTERITIS; POLYMYALGIA-RHEUMATICA; CARDIOVASCULAR-DISEASE; BALLOON ANGIOPLASTY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A systematic literature search was performed to summarise current knowledge on extracranial giant cell arteritis (GCA), i.e. large-artery involvement in patients with or without clinically apparent temporal arteritis (cranial GCA). Extracranial GCA is increasingly recognised, both in patients with cranial GCA and with solitary extracranial GCA, due to increased awareness among physicians and development of modern imaging modalities. The literature on the pathogenesis and histopathology of extracranial GCA is scarce. It is considered to be similar to cranial GCA. Patients with solitary extracranial GCA often present with non-specific signs and symptoms, although vascular manifestations, mostly secondary to stenosis, may occur. Due to the non-specific clinical presentation and low sensitivity of temporal artery biopsies, extracranial GCA is usually diagnosed by imaging. F-18-FDG-PET, MRI, CT angiography and ultrasound are used for this purpose. At present, the optimal diagnostic strategy is undetermined. The choice for a particular modality can be guided by the clinical scenario that raises suspicion of extracranial GCA, in addition to local availability and expertise. Extracranial complications in GCA consist of aortic aneurysm or dissection (mainly the ascending aorta), aortic arch syndrome, arm claudication and posterior stroke (although this is technically a cranial complication, it often results from stenosis of the vertebrobasilar arteries). Mortality is generally not increased in patients with GCA. Treatment of patients with solitary extracranial and those with extracranial and cranial GCA has been debated in the recent literature. In general, the same strategy is applied as in patients with temporal arteritis, although criteria regarding who to treat are unclear. Surgical procedures may be indicated, in which case optimal medical treatment prior to surgery is important.
引用
收藏
页码:182 / 192
页数:11
相关论文
共 50 条
  • [31] GIANT-CELL OR TEMPORAL ARTERITIS - A REVIEW
    HARRISON, CV
    JOURNAL OF CLINICAL PATHOLOGY, 1948, 1 (04) : 197 - 211
  • [32] A Review of the Dermatological Complications of Giant Cell Arteritis
    Prieto-Pena, Diana
    Castaneda, Santos
    Atienza-Mateo, Belen
    Blanco, Ricardo
    Angel Gonzalez-Gay, Miguel
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2021, 14 : 303 - 312
  • [33] EPIDEMIOLOGY OF GIANT CELL ARTERITIS: A CRITICAL REVIEW
    Watts, Richard A.
    RHEUMATOLOGY, 2014, 53 : 1 - 2
  • [34] Tocilizumab in Extracranial Large-Vessel Giant Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
    Lasa Teja, Carmen
    Loricera, Javier
    Prieto-Pena, Diana
    Lopez Gutierrez, Fernando
    Bernabeu, Pilar
    Freire Gonzalez, Mercedes
    Ferraz-Amaro, Ivan
    Castaneda, Santos
    Minguez, Mauricio
    Bravo-Mancheno, Beatriz
    Solans-Laque, Roser
    Blanco-Alonso, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1598 - 1600
  • [35] TOCILIZUMAB IN CRANIAL AND EXTRACRANIAL REFRACTORY GIANT CELL ARTERITIS: A MULTICENTER STUDY OF 312 CASES
    Sanchez-Bilbao, L.
    Loricera, J.
    Aldasoro, V.
    Melero, R.
    Castaneda, S.
    Maiz, O.
    Moriano, C.
    Villa-Blanco, I.
    Labrador-Sanchez, E.
    Hidalgo, C.
    Manrique Arija, S.
    Galindez-Agirregoikoa, E.
    Perez-Pampin, E.
    Garcia-Valle, A.
    Campos Fernandez, C.
    De Dios, J. R.
    Iniguez, C. L.
    Andreu Sanchez, L.
    Sanchez, J.
    Calderon-Goercke, M.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 34 - 35
  • [36] Giant cell arteritis as a cause of extracranial internal carotid artery aneurysm: a case report
    Kobza, Ihor
    Mota, Yuliia
    Vovk, Volodymyr
    JOURNAL OF MEDICAL CASE REPORTS, 2024, 18 (01)
  • [37] Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis
    Both, M.
    Aries, P. M.
    Mueller-Huelsbeck, S.
    Jahnke, T.
    Schaefer, P. J.
    Gross, W. L.
    Heller, M.
    Reuter, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (09) : 1124 - 1130
  • [38] Cranial and extracranial manifestations of giant cell arteritis: a single-center observational study
    Kudraszew, Emilia
    Nowakowska-Plaza, Anna
    Wronski, Jakub
    Plaza, Mateusz
    Wislowska, Malgorzata
    RHEUMATOLOGY INTERNATIONAL, 2024, 44 (08) : 1529 - 1534
  • [39] Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive Subtype
    Beuker, Carolin
    Wankner, Maximilian Christian
    Thomas, Christian
    Strecker, Jan-Kolja
    Schmidt-Pogoda, Antje
    Schwindt, Wolfram
    Schulte-Mecklenbeck, Andreas
    Gross, Catharina
    Wiendl, Heinz
    Barth, Peter J.
    Eckert, Bernd
    Meinel, Thomas Raphael
    Arnold, Marcel
    Schaumberg, Jens
    Krueger, Schulamith
    Deb-Chatterji, Milani
    Magnus, Tim
    Roether, Joachim
    Minnerup, Jens
    ANNALS OF NEUROLOGY, 2021, 90 (01) : 118 - 129
  • [40] Risk Factors and Pharmacological Interventions Impacting Cerebrovascular Ischemic Events in Giant Cell Arteritis: A Narrative Review
    Siddiqui, Muhammad Osama
    Syed, Mohammad Ali
    Qureshi, Ayaan Ahmed
    Imam, Mustafa Hussain
    Motwani, Jatin
    Kumari, Verkha
    Siddiqui, Arooba
    Ul Ain, Noor
    Jaber, Mohammed Hammad
    IMMUNITY INFLAMMATION AND DISEASE, 2025, 13 (01)